Shark single-domain antibody

By innovatively reengineering biological scaffolds, the single-domain antibody products developed from shark-derived natural heavy-chain antibodies offer several advantages over conventional antibodies, including smaller molecular size, enhanced stability, superior tissue penetration, and reduced immunogenicity. These products are applicable in areas such as targeted drug development, in vitro diagnostic reagent design, and biopharmaceutical research, while also providing customized development and large-scale production services. This product can be tailored to generate single-domain antibodies with diverse antigen specificities, supporting end-to-end services from antibody screening through to large-scale purification. The resulting antibodies meet biopharmaceutical R&D and manufacturing‑grade purity standards, and corresponding quality‑control reports are available. Currently, we have established a mature platform for shark immunization, phage‑display library construction, and screening, enabling rapid generation of high‑affinity, highly specific single-domain antibody clones against a wide range of target antigens. We can flexibly adjust development timelines to align with clients’ project schedules, ensuring efficient delivery.

Category:

Keywords:

Functional food

Pharmaceutical intermediate

Animal Nutrition

CDMO

  • 产品详情
  • By innovatively reengineering biological scaffolds, the single-domain antibody products developed from shark-derived natural heavy-chain antibodies offer several advantages over conventional antibodies, including smaller molecular size, enhanced stability, superior tissue penetration, and reduced immunogenicity. These products are applicable to targeted drug development, in vitro diagnostic reagent design, and biopharmaceutical research, while also supporting customized development and large-scale production services.

    This product can generate single-domain antibodies with diverse antigen specificities tailored to customer needs, supporting end-to-end services from antibody screening through large-scale purification. The product’s purity meets the standards required for biopharmaceutical R&D and manufacturing, and corresponding quality‑control reports are available.

    Currently, we have established a mature platform for shark‑derived immunity and for the construction and screening of phage libraries, enabling the rapid generation of single‑domain antibody clones with high affinity and specificity against a wide range of target antigens. We can flexibly adjust the development timeline to meet clients’ project deadlines, ensuring efficient delivery.

Online Consultation

If you have any questions, please leave us a message—we’ll be happy to assist you.

Recommended Products